Patents-Review.com
🔗 Permalink
Assignee profile:

Resverlogix Corp.

City:

Calgary, Alberta

Country:

Canada

Published Applications:

16

Last publication date:

2019-03-28

Patent Grants:

16

Last grant date:

2020-09-15

Top Inventors for applications by Resverlogix Corp.

These are the the leading inventors for applications assigned to Resverlogix Corp.:

Recent patent applications by Resverlogix Corp.

Resverlogix Corp. based in Calgary, Alberta, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-03-28 ✅ Patent 10,772,894 granted on 2020-09-15
US20190091235A1
Human necessities

Compositions and therapeutic methods for the treatment of complement-associated diseases

 #2 | 2018-04-19 ✅ Patent 10,532,054 granted on 2020-01-14
US20180104245A1
Human necessities

Compounds for the prevention and treatment of cardiovascular diseases

 #3 | 2017-05-04 ✅ Patent 10,016,426 granted on 2018-07-10
US20170119767A1
Human necessities

Pharmaceutical compositions for substituted quinazolinones

 #4 | 2016-09-15 ✅ Patent 10,111,885 granted on 2018-10-30
US20160263126A1
Human necessities

Compositions and therapeutic methods for the treatment of complement-associated diseases

 #5 | 2016-05-19 ✅ Patent 10,131,640 granted on 2018-11-20
US20160137613A1
Chemistry; metallurgy

Anti-inflammatory agents

 #6 | 2015-03-12 ✅ Patent 9,199,990 granted on 2015-12-01
US20150072955A1
Chemistry; metallurgy

Compounds for the prevention and treatment of cardiovascular diseases

 #7 | 2014-04-17 ✅ Patent 8,884,046 granted on 2014-11-11
US20140107369A1
Chemistry; metallurgy

Compounds useful in the synthesis of benzamide compounds

 #8 | 2013-05-02 ✅ Patent 9,610,251 granted on 2017-04-04
US20130108672A1
Human necessities

Pharmaceutical compositions for substituted quinazolinones

 #9 | 2012-03-08 ✅ Patent 9,757,368 granted on 2017-09-12
US20120059002A1
Human necessities

Anti-inflammatory agents

 #10 | 2012-02-16 ✅ Patent 9,238,640 granted on 2016-01-19
US20120040954A1
Chemistry; metallurgy

Anti-inflammatory agents

 #11 | 2012-01-19 ✅ Patent 8,889,698 granted on 2014-11-18
US20120015905A1
Human necessities

Compounds for the prevention and treatment of cardiovascular diseases

 #12 | 2011-12-01 ✅ Patent 8,952,021 granted on 2015-02-10
US20110294807A1
Chemistry; metallurgy

Compounds for the prevention and treatment of cardiovascular disease

 #13 | 2011-04-07 ✅ Patent 8,242,144 granted on 2012-08-14
US20110082176A1
Chemistry; metallurgy

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

 #14 | 2009-10-15 ✅ Patent 8,242,130 granted on 2012-08-14
US20090259048A1
Chemistry; metallurgy

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

 #15 | 2009-01-29 ✅ Patent 8,410,109 granted on 2013-04-02
US20090029987A1
Chemistry; metallurgy

Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices

 #16 | 2006-09-14 ✅ Patent 8,093,273 granted on 2012-01-10
US20060205767A1
Chemistry; metallurgy

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
AssigneeID:

447673 ⎘